JP Morgan Says ResMed Bundling Issue Is Less Of A Problem
June 10, 2014 at 13:15 PM EDT
JP Morgan analyst Steve Wheen said that ResMed's (NYSE: RMD) bundling issue is shaping up to be less of a problem than he previously ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.